Praxis Precision Medicines, Inc. PRAX

Updated: 8 Sep 2026

NASDAQ | Biotech | CNS precision biopharmaceuticals

No signal published yet

We already track Praxis Precision Medicines and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Praxis Precision Medicines free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
CNS precision biopharmaceuticals
We're already tracking Praxis Precision Medicines, Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, Praxis Precision Medicines reported its second-quarter 2026 financial results, ending the period with $1.4 billion in total cash and marketable securities. The company confirmed that mid-cycle FDA review meetings for lead candidates ulixacaltamide and relutrigine were completed without major issues or advisory committee requirements. FDA target action dates under PDUFA were set for December 27, 2026 for relutrigine and January 29, 2027 for ulixacaltamide.

What Firelda Watch includes for Praxis Precision Medicines, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Praxis Precision Medicines, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Boozt AB (publ)
BOOZT
HOLD
Vitrolife AB (publ)
VITR
HOLD
Lagercrantz Group
LAGR B
NEUTRAL
Tetra Tech, Inc.
TTEK
HOLD
Vicore Pharma Holding AB (publ)
VICO
HOLD

Biotech

More companies in this sector

Want to follow Praxis Precision Medicines, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Praxis Precision Medicines free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Praxis Precision Medicines, Inc. PRAX
Praxis Precision Medicines — follow and we'll monitor it
Follow Praxis Precision Medicines free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.